Patheon to Present at 2015 J.P. Morgan Global High Yield and Leveraged Finance Conference
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced today that James C. Mullen, CEO, will present an update on the company’s financial standing at the J.P. Morgan Global High Yield and Leveraged Finance Conference at the Loews Miami Beach Hotel in Miami, on Monday, Feb. 23 at 4 p.m.
Patheon Media Relations
Tel: +1 (919) 210-0986
Patheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence to customers in the pharmaceutical and biopharma sector. A leading global provider with more than 8,000 employees worldwide, Patheon has a comprehensive set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. For more information, visit http://www.patheon.com.